Mevalonate Blockade in Cancer Cells Triggers CLEC9A+ Dendritic Cell-Mediated Antitumor Immunity.
Xu F, Wang Z, Zhang H, Chen J, Wang X, Cui L, Xie C, Li M, Wang F, Zhou P, Liu J, Huang P, Xia X, Xia X.
Xu F, et al. Among authors: wang x, wang f, wang z.
Cancer Res. 2021 Sep 1;81(17):4514-4528. doi: 10.1158/0008-5472.CAN-20-3977. Epub 2021 Jul 15.
Cancer Res. 2021.
PMID: 34266895